$ATEC

MCGINNIS KAREN K sold $48K of ATEC

MCGINNIS KAREN K sold 6,050 shares of Alphatec Holdings, Inc. (ATEC) at $8.01 on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MCGINNIS KAREN K
Published Jun 12, 2026, 9:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 9:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATEC
Neutral
medium confidence
Mentioned
$ATEC
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATECNeutralLow
01

Why it matters

The disclosure confirms a director open-market sale of 6,050 shares at $8.01/share, executed under a pre-arranged 10b5-1 plan; it does not include any new operational, financial, or regulatory developments.

02

Market read

Traders may monitor for incremental insider activity, but this specific filing is unlikely to drive a major repricing without additional catalysts.

03

What to watch

Check for clustering of insider sales/buys around the same period; a single planned sale is less informative than a pattern.

Relevance 2/10Novelty 6/10Timing: Filed 2026-06-12; sale executed 2026-06-11

Background

The filing is an SEC Form 4 insider transaction for Alphatec Holdings, Inc. (ATEC).

Company-level read

Ticker impact

$ATECNeutralMedium confidence
Context

Alphatec director Karen McGinnis sold 6,050 shares in an open-market transaction on 2026-06-11 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited/short-lived impact; treat as low-signal unless follow-on insider activity accelerates.

Evidence & confidence

Form 4 is a primary disclosure, but the article provides no new company-specific catalyst beyond a planned sale.

Market effects

No sector-level read-across; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can be purely mechanical; the market may overreact to the headline “sell” despite no change in fundamentals.

Key entities

  • Alphatec Holdings, Inc.

    Company whose director insider sale is disclosed on SEC Form 4.

  • Karen McGinnis

    Director who sold 6,050 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

$ATECMedAI 8/10

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.